Emphysema Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 73 pages | ID: EB57A4568048EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Emphysema Drug in global, including the following market information:

Global Emphysema Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Emphysema Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Emphysema Drug companies in 2021 (%)

The global Emphysema Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

BB-3 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Emphysema Drug include Angion Biomedica Corp., ProMetic Life Sciences Inc., rEVO Biologics, Inc., SATT North SAS and TGV-Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Emphysema Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Emphysema Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Emphysema Drug Market Segment Percentages, by Type, 2021 (%)

• BB-3
• EDO-66
• MG-53
• Others

Global Emphysema Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Emphysema Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Emphysema Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Emphysema Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Emphysema Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Emphysema Drug revenues share in global market, 2021 (%)

Key companies Emphysema Drug sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Emphysema Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Angion Biomedica Corp.
• ProMetic Life Sciences Inc.
• rEVO Biologics, Inc.
• SATT North SAS
• TGV-Laboratories

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Emphysema Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Emphysema Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EMPHYSEMA DRUG OVERALL MARKET SIZE

2.1 Global Emphysema Drug Market Size: 2021 VS 2028
2.2 Global Emphysema Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Emphysema Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Emphysema Drug Players in Global Market
3.2 Top Global Emphysema Drug Companies Ranked by Revenue
3.3 Global Emphysema Drug Revenue by Companies
3.4 Global Emphysema Drug Sales by Companies
3.5 Global Emphysema Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Emphysema Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Emphysema Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Emphysema Drug Players in Global Market
  3.8.1 List of Global Tier 1 Emphysema Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Emphysema Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Emphysema Drug Market Size Markets, 2021 & 2028
  4.1.2 BB-3
  4.1.3 EDO-66
  4.1.4 MG-53
  4.1.5 Others
4.2 By Type - Global Emphysema Drug Revenue & Forecasts
  4.2.1 By Type - Global Emphysema Drug Revenue, 2017-2022
  4.2.2 By Type - Global Emphysema Drug Revenue, 2023-2028
  4.2.3 By Type - Global Emphysema Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Emphysema Drug Sales & Forecasts
  4.3.1 By Type - Global Emphysema Drug Sales, 2017-2022
  4.3.2 By Type - Global Emphysema Drug Sales, 2023-2028
  4.3.3 By Type - Global Emphysema Drug Sales Market Share, 2017-2028
4.4 By Type - Global Emphysema Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Emphysema Drug Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Emphysema Drug Revenue & Forecasts
  5.2.1 By Application - Global Emphysema Drug Revenue, 2017-2022
  5.2.2 By Application - Global Emphysema Drug Revenue, 2023-2028
  5.2.3 By Application - Global Emphysema Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Emphysema Drug Sales & Forecasts
  5.3.1 By Application - Global Emphysema Drug Sales, 2017-2022
  5.3.2 By Application - Global Emphysema Drug Sales, 2023-2028
  5.3.3 By Application - Global Emphysema Drug Sales Market Share, 2017-2028
5.4 By Application - Global Emphysema Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Emphysema Drug Market Size, 2021 & 2028
6.2 By Region - Global Emphysema Drug Revenue & Forecasts
  6.2.1 By Region - Global Emphysema Drug Revenue, 2017-2022
  6.2.2 By Region - Global Emphysema Drug Revenue, 2023-2028
  6.2.3 By Region - Global Emphysema Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Emphysema Drug Sales & Forecasts
  6.3.1 By Region - Global Emphysema Drug Sales, 2017-2022
  6.3.2 By Region - Global Emphysema Drug Sales, 2023-2028
  6.3.3 By Region - Global Emphysema Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Emphysema Drug Revenue, 2017-2028
  6.4.2 By Country - North America Emphysema Drug Sales, 2017-2028
  6.4.3 US Emphysema Drug Market Size, 2017-2028
  6.4.4 Canada Emphysema Drug Market Size, 2017-2028
  6.4.5 Mexico Emphysema Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Emphysema Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Emphysema Drug Sales, 2017-2028
  6.5.3 Germany Emphysema Drug Market Size, 2017-2028
  6.5.4 France Emphysema Drug Market Size, 2017-2028
  6.5.5 U.K. Emphysema Drug Market Size, 2017-2028
  6.5.6 Italy Emphysema Drug Market Size, 2017-2028
  6.5.7 Russia Emphysema Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Emphysema Drug Market Size, 2017-2028
  6.5.9 Benelux Emphysema Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Emphysema Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Emphysema Drug Sales, 2017-2028
  6.6.3 China Emphysema Drug Market Size, 2017-2028
  6.6.4 Japan Emphysema Drug Market Size, 2017-2028
  6.6.5 South Korea Emphysema Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Emphysema Drug Market Size, 2017-2028
  6.6.7 India Emphysema Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Emphysema Drug Revenue, 2017-2028
  6.7.2 By Country - South America Emphysema Drug Sales, 2017-2028
  6.7.3 Brazil Emphysema Drug Market Size, 2017-2028
  6.7.4 Argentina Emphysema Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Emphysema Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Emphysema Drug Sales, 2017-2028
  6.8.3 Turkey Emphysema Drug Market Size, 2017-2028
  6.8.4 Israel Emphysema Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Emphysema Drug Market Size, 2017-2028
  6.8.6 UAE Emphysema Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Angion Biomedica Corp.
  7.1.1 Angion Biomedica Corp. Corporate Summary
  7.1.2 Angion Biomedica Corp. Business Overview
  7.1.3 Angion Biomedica Corp. Emphysema Drug Major Product Offerings
  7.1.4 Angion Biomedica Corp. Emphysema Drug Sales and Revenue in Global (2017-2022)
  7.1.5 Angion Biomedica Corp. Key News
7.2 ProMetic Life Sciences Inc.
  7.2.1 ProMetic Life Sciences Inc. Corporate Summary
  7.2.2 ProMetic Life Sciences Inc. Business Overview
  7.2.3 ProMetic Life Sciences Inc. Emphysema Drug Major Product Offerings
  7.2.4 ProMetic Life Sciences Inc. Emphysema Drug Sales and Revenue in Global (2017-2022)
  7.2.5 ProMetic Life Sciences Inc. Key News
7.3 rEVO Biologics, Inc.
  7.3.1 rEVO Biologics, Inc. Corporate Summary
  7.3.2 rEVO Biologics, Inc. Business Overview
  7.3.3 rEVO Biologics, Inc. Emphysema Drug Major Product Offerings
  7.3.4 rEVO Biologics, Inc. Emphysema Drug Sales and Revenue in Global (2017-2022)
  7.3.5 rEVO Biologics, Inc. Key News
7.4 SATT North SAS
  7.4.1 SATT North SAS Corporate Summary
  7.4.2 SATT North SAS Business Overview
  7.4.3 SATT North SAS Emphysema Drug Major Product Offerings
  7.4.4 SATT North SAS Emphysema Drug Sales and Revenue in Global (2017-2022)
  7.4.5 SATT North SAS Key News
7.5 TGV-Laboratories
  7.5.1 TGV-Laboratories Corporate Summary
  7.5.2 TGV-Laboratories Business Overview
  7.5.3 TGV-Laboratories Emphysema Drug Major Product Offerings
  7.5.4 TGV-Laboratories Emphysema Drug Sales and Revenue in Global (2017-2022)
  7.5.5 TGV-Laboratories Key News

8 GLOBAL EMPHYSEMA DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Emphysema Drug Production Capacity, 2017-2028
8.2 Emphysema Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Emphysema Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 EMPHYSEMA DRUG SUPPLY CHAIN ANALYSIS

10.1 Emphysema Drug Industry Value Chain
10.2 Emphysema Drug Upstream Market
10.3 Emphysema Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Emphysema Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Emphysema Drug in Global Market
Table 2. Top Emphysema Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Emphysema Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Emphysema Drug Revenue Share by Companies, 2017-2022
Table 5. Global Emphysema Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Emphysema Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Emphysema Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Emphysema Drug Product Type
Table 9. List of Global Tier 1 Emphysema Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Emphysema Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Emphysema Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Emphysema Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Emphysema Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Emphysema Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Emphysema Drug Sales (K Pcs), 2023-2028
Table 16. By Application – Global Emphysema Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Emphysema Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Emphysema Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Emphysema Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Emphysema Drug Sales (K Pcs), 2023-2028
Table 21. By Region – Global Emphysema Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Emphysema Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Emphysema Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Emphysema Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Emphysema Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Emphysema Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Emphysema Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Emphysema Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Emphysema Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Emphysema Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Emphysema Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Emphysema Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Emphysema Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Emphysema Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Emphysema Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Emphysema Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Emphysema Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Emphysema Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Emphysema Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Emphysema Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Emphysema Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Emphysema Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Emphysema Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Emphysema Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Emphysema Drug Sales, (K Pcs), 2023-2028
Table 46. Angion Biomedica Corp. Corporate Summary
Table 47. Angion Biomedica Corp. Emphysema Drug Product Offerings
Table 48. Angion Biomedica Corp. Emphysema Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. ProMetic Life Sciences Inc. Corporate Summary
Table 50. ProMetic Life Sciences Inc. Emphysema Drug Product Offerings
Table 51. ProMetic Life Sciences Inc. Emphysema Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. rEVO Biologics, Inc. Corporate Summary
Table 53. rEVO Biologics, Inc. Emphysema Drug Product Offerings
Table 54. rEVO Biologics, Inc. Emphysema Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. SATT North SAS Corporate Summary
Table 56. SATT North SAS Emphysema Drug Product Offerings
Table 57. SATT North SAS Emphysema Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. TGV-Laboratories Corporate Summary
Table 59. TGV-Laboratories Emphysema Drug Product Offerings
Table 60. TGV-Laboratories Emphysema Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Emphysema Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 62. Global Emphysema Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Emphysema Drug Production by Region, 2017-2022 (K Pcs)
Table 64. Global Emphysema Drug Production by Region, 2023-2028 (K Pcs)
Table 65. Emphysema Drug Market Opportunities & Trends in Global Market
Table 66. Emphysema Drug Market Drivers in Global Market
Table 67. Emphysema Drug Market Restraints in Global Market
Table 68. Emphysema Drug Raw Materials
Table 69. Emphysema Drug Raw Materials Suppliers in Global Market
Table 70. Typical Emphysema Drug Downstream
Table 71. Emphysema Drug Downstream Clients in Global Market
Table 72. Emphysema Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Emphysema Drug Segment by Type
Figure 2. Emphysema Drug Segment by Application
Figure 3. Global Emphysema Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Emphysema Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Emphysema Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Emphysema Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Emphysema Drug Revenue in 2021
Figure 9. By Type - Global Emphysema Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Emphysema Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Emphysema Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Emphysema Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Emphysema Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Emphysema Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Emphysema Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Emphysema Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Emphysema Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Emphysema Drug Sales Market Share, 2017-2028
Figure 19. US Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Emphysema Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Emphysema Drug Sales Market Share, 2017-2028
Figure 24. Germany Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Emphysema Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Emphysema Drug Sales Market Share, 2017-2028
Figure 33. China Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Emphysema Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Emphysema Drug Sales Market Share, 2017-2028
Figure 40. Brazil Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Emphysema Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Emphysema Drug Sales Market Share, 2017-2028
Figure 44. Turkey Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Emphysema Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Emphysema Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Emphysema Drug by Region, 2021 VS 2028
Figure 50. Emphysema Drug Industry Value Chain
Figure 51. Marketing Channels